Investigating the role of a specific gene in Parkinson's disease.
The Role of GPNMB in Parkinson's Disease.
This study is looking at how a specific gene might play a role in Parkinson's disease and related dementias, using advanced techniques to see how changes in this gene affect brain health, with the hope that it will lead to new treatments for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albert Einstein College of Medicine NIH-funded |
| Lab location | 1 site (Bronx, United States) |
| Project ID | NIH-10981453 on NIH RePORTER |
What this research studies
This research focuses on understanding how genetic factors, particularly the GPNMB gene, contribute to the development of Parkinson's disease and related dementias. By using advanced techniques like CRISPR/Cas9 in human stem cells, the study aims to explore how variations in this gene affect neuroinflammation and neurodegeneration. The researchers will analyze genetic data alongside epigenetic information to identify how these factors interact and influence disease progression. Patients may benefit from insights that could lead to new therapeutic strategies targeting these genetic pathways.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Parkinson's disease, Lewy Body Dementia, or related neurodegenerative disorders.
Not a fit: Patients with neurodegenerative diseases not related to Parkinson's or Lewy Body Dementia may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that specifically target the genetic factors involved in Parkinson's disease and related dementias.
How similar studies have performed: Previous research has shown promise in understanding genetic contributions to neurodegenerative diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
Bronx, United States
- Albert Einstein College of Medicine — Bronx, United States (Active)
Researchers
- Principal investigator: Soldner, Frank — Albert Einstein College of Medicine
- Study coordinator: Soldner, Frank
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.